Authors showed that at level of human carotid atherosclerotic plaques, TIMP3 was significantly impaired in patients with type 2 diabetes, leading to A Disintegrin And Metalloproteinase (ADAM17) and MMP9 overactivity. This evidence concerns the gene TIMP3 and type 2 diabetes mellitus.